🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07062367
Recruiting Not applicable

Sevoflurane With or Without Intravenous Lidocaine Infusion Versus Propofol Anesthesia on Intracranial Pressure and Cerebral Oxygenation During Laparoscopic Hysterectomy

NCT07062367 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-02-01
Last updated
2025-07-14

Condition(s) studied

SevofluraneLidocainePropofolIntracranial PressureCerebral OxygenationLaparoscopic Hysterectomy

Investigational drug(s) / intervention(s)

Propofol →Sevoflurane plus lidocaine infusionAll Sevoflurane trials (24) →All Lidocaine trials (58) →Sevoflurane →

Propofol: Patients' anesthesia will be maintained by manually adjusted propofol infusion at a rate of 100-250 mic/kg/min for bispectral index (BIS) maintained between 40-60.

Sevoflurane plus lidocaine infusion: Sevoflurane with monitored anesthesia care (MAC) adjusted to maintain bispectral index (BIS) between 40-60 plus intravenous lidocaine infusion given as 2mg /kg IV bolus before induction then intraoperative infusion by a rate of 2 mg/kg/h until the end of surgery.

Sevoflurane: Patients will receive sevoflurane with monitored anesthesia care (MAC) adjusted to maintain bispectral index (BIS) between 40-60.

Study summary

This study will be conducted to evaluate the effects of different anesthetic modalities \[sevoflurane with or without intraoperative lidocaine infusion and Propofol total intravenous anesthesia (TIVA)\] on intracranial pressure (ICP) and cerebral oxygenation assessed by non-invasive methods during laparoscopic hysterectomy (LH).

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age from 18 to 65 years. * American Society of Anesthesiologists (ASA) physical status I and Ⅱ. * Body mass index (BMI) ≤35. * Females scheduled for laparoscopic hysterectomy. Exclusion Criteria: * Patients' refusal to participate in the study. * Hypersensitivity and allergy to drugs of the study. * Contraindication for optic nerve sheath diameter assessment. E.g., patient with pre-existing ophthalmic diseases, a history of ophthalmic surgery * Any central nervous system or cardiovascular disease, severe hepatic or renal impairment * Intraoperative circumstances, such as inability to perform optic nerve sheath diameter or conversion to open surgery * If peak inspiratory pressure (PIP) exceeds 35.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta El-Gharbia Recruiting

More Tanta University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07062367 on ClinicalTrials.gov ↗ ← All trials in Egypt